Skip to Main Content (Press Enter)

×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze

UNI-FIND

|

UNI-FIND

unimore.it

×
Home
Corsi
Insegnamenti
Professioni
Persone
Pubblicazioni
Strutture
Terza Missione
Attività
Competenze

Pubblicazioni

ANNALS OF ONCOLOGY

Rivista

Codice:

E009451

ISSN:

0923-7534

Dati Generali

Dati Generali

Pubblicazioni (155)

Ordina Pubblicazioni:

ascendente
decrescente

3* Final analysis of the phase III multicentric Italian study Short-HER: 9 weeks vs 1 year adjuvant trastuzumab for HER2+ early breast cancer

Abstract

5P Anti-GD2 chimeric antigen receptor & TRAIL modified mesenchymal progenitors as novel strategy against Ewing’s sarcoma

Abstract

9 weeks versus 1 year adjuvant trastuzumab for HER2+ early breast cancer: Subgroup analysis of the ShortHER trial allows to identify patients for whom a shorter trastuzumab administration may have a favourable risk/benefit ratio

Abstract

9 weeks vs 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study.

Articolo

: Late toxicity and quality of life (QOL) after treatment for Hodgkin disease (HD): A Gruppo Italiano Studio Linfomi (GISL) cohort study on 223 patients

Abstract

A PROSPECTIVE, RANDOMIZED, PHASE II STUDY OFGISL COMPARING TWO MITOXANTRONE-BASED SALVAGEPROGRAM (MIPE VS MJMA) IN AGGRESSIVE NON-HODGKIN’SLYMPHOMA (ANHL) FAILING AN ANTHRACYCLINECONTAININGFRONT-LINE TREATMENT

Abstract

A diachronic-comparative analysis for the identification of the most powerful prognostic index for localized diffuse large B-cell lymphoma

Articolo

A model for predicting the risk of developing mild anemia (MA) in patients with lymphoid malignancy. A study of the Gruppo Italiano Studio Linfomi (GISL)

Abstract

A multigenomic liquid biopsy biomarker for neuroendocrine tumor disease outperforms CgA and has surgical and clinical utility

Articolo

A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy

Articolo

A novel approach to manage skin toxicity caused by therapeutic agents targeting epidermal growth factor receptor.

Articolo

A phase I, dose-escalation study of volasertib combined with nintedanib in advanced solid tumors

Articolo

A prognostic model based on nodal status and Ki-67 predicts the risk of recurrence and death in breast cancer patients with residual disease after preoperative chemotherapy

Articolo

A rapid genetic counselling and testing in newly diagnosed breast cancer is associated with high rate of risk-reducing mastectomy in BRCA1/2-positive italian women

Articolo

A user-friendly nomogram to predict relapse-free survival (RFS) in western patients with resected gastric cancer (GC)

Abstract

A-BRAVE trial: a phase III randomized trial with anti-PD-L1 avelumab in high-risk triple-negative early breast cancer patients.

Articolo

ABVD plus radiotherapy versus EVE plus radiotherapy in unfavorable stage IA and IIA Hodgkin's lymphoma: results from an Intergruppo Italiano Linfomi randomized study.

Articolo

ABVD versus Stanford V versus MEC in unfavourable Hodgkin's lymphoma: results of a randomised trial

Articolo

Accelerated versus standard cyclophosphamide, epirubicin and 5-fluorouracil or cyclophosphamide, methotrexate and 5-fluorouracil: a randomized phase III trial in locally advanced breast cancer

Articolo

Activating c-kit mutations in a subset of thymic carcinoma and response to different c-kit inhibitors

Articolo

Acute myeloid leukemia in patients previously diagnosed with breast cancer: Experience of the GIMEMA group

Articolo

Adjuvant chemoterapy in the tratment of colon cancer: randomized multicenter trial of the Italian National Intergroup of Adjuvant Chemotherapy in Colon Cancer (INTACC).

Articolo

Advanced epithelial ovarian cancer: 1993 consensus statements.

Articolo

Advanced ovarian cancer. Carboplatin versus cisplatin.

Contributo in Atti di convegno

Aggressive non-Hodgkin's lymphoma in the elderly: A validated prognostic evaluation performed by the Gruppo Italiano per lo Studio dei Linfomi (GISL)

Articolo

Allele polymorphisms of tumor integrins correlate with peritoneal carcinosis capability of gastric cancer cells in radically resected patients.

Articolo

An oncologist-based model of cancer genetic counselling for hereditary breast and ovarian cancer

Articolo

An open label expanded access study of lapatinib and capecitabine in patients with HER2-overexpressing locally advanced or metastatic breast cancer

Articolo

Analysis of BCL-10 gene mutations in ovarian cancer cell lines.

Articolo

Analysis of HER-3, insulin growth factor-1, nuclear factor-kB and epidermal growth factor receptor gene copy number in the prediction of clinical outcome for K-RAS wild-type colorectal cancer patients receiving irinotecan-cetuximab.

Articolo

Analysis of diffuse large B cell lymphomas (DLBCL) transcriptional profiles at chromosomal level

Abstract

Anthracycline-based chemotherapy as primary treatment for intravascular lymphoma

Articolo

Anthracyclines paclitaxel combinations in the treatment of breast cancer.

Articolo

Antiviral treatment in patients with indolent B-cell lymphomas associated with HCV infection: a study of the Fondazione Italiana Linfomi

Articolo

Association of tumor-infiltrating lymphocytes with distant disease-free survival in the ShortHER randomized adjuvant trial for patients with early HER2+ breast cancer.

Articolo

BRCA mutations among triple negative breast cancer without family history of breast and ovarian cancer: The Modena family cancer clinic experience

Abstract

CDX-2 homeobox gene and MUC2 expression identifies true mucinous (so-called colloid) carcinoma of the lung and justifies its indolent outcome

Abstract

CLINICAL OUTCOMES AND SURVIVAL IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND HIV INFECTION

Abstract

Cancer prevalence in European registry areas.

Articolo

Cancer profile in Eastern Libya: incidence and mortality in the year 2004.

Articolo

Centroblastic (CB) and immunoblastic (IB) subtypes of diffuse large B cell lymphomas (DLBCL) have such a different clinical outcome that should be considered as separate entities in the WHO classification of lymphomas. A GISL study

Articolo

Cetuximab rechallenge in metastatic colorectal cancer patients: how to come away from acquired resistance?

Articolo

Chemotherapy with or without estrogenic recruitment in metastatic breast cancer. A randomized trial of the Gruppo Oncologico Nord Ovest (GONO).

Articolo

Childhood cancer survival in Europe

Articolo

Clinical activity of bortezomib in relapsed/refractory MALT lymphomas: results of a phase II study of the International Extranodal Lymphoma Study Group (IELSG)

Articolo

Clinico-pathological characterization of hepatitis C virus-related B-cell non-Hodgkin's lymphomas without symptomatic cryoglobulinemia

Articolo

Colon cancer prevalence and estimation of differing care needs of colon cancer patients

Articolo

Comment on "Cancer genetic counselling' by P.!Mandich et al. (Ann Oncol 2005; 16: 171)

Articolo

Continuous-infusion 5-fluorouracil in metastatic colorectal cancer patients pretreated with bolus 5-fluorouracil: clinical evidence of incomplete cross-resistance.

Articolo

Corrigendum to “Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”: [Annals of Oncology 32 (2021) 439–451](S0923753421000119)(10.1016/j.annonc.2021.01.003)

Articolo

Corrigendum: ESMO consensus conference on malignant lymphoma: General perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia. [Ann Oncol 27, (2016) (2149-2160)] DOI: 10.1093/annonc/mdw419

Articolo

Decreasing incidence of gastric MALT lymphomas in the era of anti-Helicobacter pilori interventions: results from a population-based study on extranodal marginal zone lymphomas

Articolo

Development and psychometric testing of a measure of perception of care dependency in cancer patients

Abstract

Differences among young adults, adults and elderly chronic myeloid leukemia patients

Articolo

Differential gene expression patterns in HER2 positive metastatic breast cancer patients according to hormone receptor status.

Abstract

Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single Institution analysis

Articolo

ESMO Consensus Conference on malignant lymphoma: general perspectives and recommendations for the clinical management of the elderly patient with malignant lymphoma

Articolo

ESMO consensus conference on malignant lymphoma: general perspectives and recommendations for prognostic tools in mature B-cell lymphomas and chronic lymphocytic leukaemia

Articolo

ESMO guidelines consensus conference on malignant lymphoma 2011 part 1: diffuse large B-cell (DLBCL), follicular lymphoma (FL) and chronic lymphocytic leukemia (CLL)

Articolo

EUROCARE-3 summary: Cancer survival in Europe at the end of the 20th century

Articolo

EUROCARE-3: survival of cancer patients diagnosed 1990–94—results and commentary

Articolo

Efficacy and safety of neoadjuvant chemotherapy plus trastuzumab and pertuzumab in non-metastatic HER2-positive breast cancer in real life: NEOPEARL study.

Poster

Endocrine therapy alone versus targeted combination strategy as first line treatment in elderly patients with hormone receptor-positive advanced breast cancer: Meta-analysis of phase II and III randomized clinical trial

Abstract

Epidermal growth factor receptor gene copy number, K-ras mutation and pathological response to preoperative cetuximab, 5-FU and radiation therapy in locally advanced rectal cancer..

Articolo

FLORENCE: A randomized, double-blind, phase III pivotal study of febuxostat versus allopurinol for the prevention of tumor lysis syndrome (TLS) in patients with hematologic malignancies at intermediate to high TLS risk

Articolo

FLUDARABINE AND CYCLOPHOSPHAMIDE FOR THE TREATMENT OF PATIENTS WITH INDOLENT NON-FOLLICULAR (INFL) B-CELL NON-HODGKIN'S LYMPHOMAS. PRELIMINARY RESULTS OF A PHASE II TRIAL OF THE 'GRUPPO ITALIANO PER LO STUDIO DEI LINFOMI (GISL)

Abstract

Factors that influence achievment of complete remission and its duration after polychemotherapy in follicular non Hodgikin's lymphoma.

Abstract

Feasibility of allogeneic stem-cell transplantation after azacitidine bridge in higher-risk myelodysplastic syndromes and low blast count acute myeloid leukemia: results of the BMT-AZA prospective study

Articolo

Final results of a phase II, double blind, placebo controlled, randomized trial of preoperative chemotherapy +/- gefitinib with biomarker evaluation in operable breast cancer

Abstract

First-line treatment for endocrine sensitive bone-only metastatic breast cancer: Is more always better?

Abstract

GLIOMATOSIS CEREBRI: A SINGLE INSTITUTION REPORT

Abstract

Gemcitabine, epirubicin and paclitaxel: Pharmacokinetic and pharmacodynamic interactions in advanced breast cancer

Articolo

Gene expression profiling of plasma cell dyscrasias reveals molecular patterns associated with distinct IGH translocations in multiple myeloma

Abstract

High-dose thiotepa and melphalan with hemopoietic progenitor support following induction therapy with epirubicin-paclitaxel-containing regimens in metastatic breast cancer (MBC)

Articolo

Hodgkin lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Articolo

Immune infiltrate composition across intrinsic subtypes in hormone receptor (HR)+/HER2- early breast cancer (BC) enrolled in the prospective LETLOB trial.

Poster

Immune-inflammatory and clinicopathologic prognostic factors in a Western cohort of resected gastric cancers (GCs)

Abstract

Impact of early access to a palliative/supportive care intervention on pain management in patients with cancer.

Articolo

Impact of hepatitis C virus infection on clinical features, quality of life and survival of patients with lymphoplasmacytoid lymphoma/immunocytoma

Articolo

Impact of hormone receptor status and tumor subtypes of breast cancer in young BRCA carriers

Articolo

Impact of setting of care on pain management in patients with cancer: a multicentre cross-sectional study.

Articolo

Impact of time to surgery after neoadjuvant chemotherapy in patients with operable breast cancer.

Abstract

Integrated evaluation of PAM50 subtypes and immune modulation of pCR in HER2-positive breast cancer patients treated with chemotherapy and HER2-targeted agents in the CherLOB trial

Articolo

International Working Group consensus response evaluation criteria in lymphoma (RECIL 2017)

Articolo

Is endoscopic ultrasound clinically useful for follow-up of gastric lymphoma?

Articolo

LOCAL RECURRENCE AFTER NEO-ADJUVANT CHEMOTHERAPY AND BREAST CONSERVING SURGERY

Abstract

Large genomic aberrations detected by SNP array are independent prognosticators of a shorter time to first treatment in chronic lymphocytic leukemia patients with normal FISH

Articolo

Long term results of alpha interferon as initial therapy and splenectomy as consolidation therapy in patients with hairy cell leukemia. Final report from the Italian cooperative group for HCL

Articolo

Long-term survival results of a randomized trial comparing gemcitabine/cisplatin and methotrexate/vinblastine/doxorubicin/cisplatin in patients with locally advanced and metastatic bladder cancer

Articolo

Loss of HER2 positivity and prognosis after neoadjuvant therapy in HER2-positive breast cancer patients

Articolo

Lung and thymic carcinoids: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Articolo

M09Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer

Abstract

MITO END-3: efficacy of avelumab immunotherapy according to molecular profiling in first-line endometrial cancer therapy

Articolo

MOPPEBVCAD CHEMOTHERAPY WITH LIMITED RADIOTHERAPYIN ADVANCED HODGKIN’S LYMPHOMA: 10-YEARRESULTS

Abstract

Maximum tolerable doses of intravenous zidovudine in combination with 5-fluorouracil and leucovorin in metastatic colorectal cancer patients. Clinical evidence of significant antitumor activity and enhancement of zidovudine-induced DNA single strand breaks in peripheral nuclear blood cells.

Articolo

Measuring cancer prevalence in Europe: The EUROPREVAL project

Articolo

Metaplastic carcinoma with extensive dendritic cell differentiation: a previously unrecognised type of triple-negative breast cancer

Articolo

Molecular profile in primary and metastatic breast cancer treated with Exemestane and Everolimus.

Abstract

Molecular profiles associated with cyclins D dysregulation and IGH translocations in multiple myeloma

Abstract

Multicentre validation of an immune-inflammation-based nomogram to predict survival in western resectable gastroesophageal adenocarcinoma: The NOMOGAST

Abstract

Multicentric prospective study of validation of angiogenesis polymorphisms in HCC patients treated with sorafenib. INNOVATE study

Abstract

Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era

Articolo

Natural history of bone metastasis in colorectal cancer: final results of a large Italian bone metastases study.

Articolo

Neoadjuvant treatment with Bevacizumab and FOLFOX-6 in patients with liver metastasis from colorectal cancer: preliminary results of a Phase II study.

Poster

Nivolumab-induced cholangitic liver disease: A novel form of serious liver injury

Articolo

Nonpegylated liposomal doxorubicin (Myocet) combination (R-COMP) chemotherapy in elderly patients with diffuse large B-cell lymphoma (DLBCL): results from the phase II EURO 18 trial

Articolo

Octreotide acetate long-acting release in patients with metastatic neuroendocrine tumors pretreated with lanreotide

Articolo

Ovarian Cancer: optimal chemotherapy in relapsed disease.

Articolo

Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high-risk, early breast cancer

Articolo

Oxaliplatin and capecitabine (Xelox) in association with highly active antiretroviral therapy in advanced hepatocarcinoma HIV/HCV-infected patients

Articolo

P53 EXPRESSION IS A SIGNIFICANT PREDICTOR OF RESPONSE AND PROGNOSIS IN STAGE II-III BREAST CANCER PATIENTS TREATED WITH PREOPERATIVE CHEMOTHERAPY

Abstract

PD-L1 marks a subset of melanomas with a shorter overall survival and distinct genetic and morphological characteristics

Articolo

PIK3CA MUTATIONS IN HER2-POSITIVE BREAST CANCER PATIENTS ENROLLED IN THE ADJUVANT RANDOMIZED SHORT-HER STUDY.

Poster

Paclitaxel and vinorelbine in anthracycline pretreated breast cancer: a phase II study.

Articolo

Parathyroid hormone-related protein in metastatic breast cancer induced hypercalcemia: A case report

Articolo

Phase II study of vinorelbine/ifosfamide/cisplatin for the treatment of advanced non-small-cell lung cancer.

Articolo

Phase II trial of estramustine phosphate and oral etoposide in patients with hormone-refractory prostate cancer

Articolo

Pre and post anti Her-2 therapy era: a mono-institutional analysis of the outcome in patients with residual disease after neoadjuvant therapy for Her-2 positive locally advanced breast cancer.

Abstract

Prescription of opioids in Italy: everything, but the morphine.

Articolo

Primary Systemic Therapy in operable breast cancer: clinical data and biological fall-out

Articolo

Primary plasma cell leukemia: A retrospective multicenter study of 73 patients

Articolo

Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer

Articolo

Professional failure: how do oncologists feel it?

Articolo

Prognostic models for diffuse large B-cell lymphoma in the rituximab era: a never-ending story.

Articolo

Prognostic value of total tumor regression after pre-operative chemo-radiotherapy in rectal cancer (RC)

Abstract

Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids

Articolo

Quantification of circulating cell-free DNA by fluorimetry (Qubit) and spectrophotometry (NanoDrop) in patients with malignant melanoma and prostate cancer

Abstract

Radioimmunotherapy versus autologous hematopoietic stem cell transplantation in relapsed/refractory follicular lymphoma: a Fondazione Italiana Linfomi multicenter, randomized, phase III trial

Articolo

Ramucirumab (RAM) as Second-Line Treatment in Patients with Advanced Hepatocellular Carcinoma (HCC) Following First-Line Therapy with Sorafenib: Analyses from the Randomized Phase III REACH Study

Articolo

Randomized phase III trials of adjuvant FAMTX or FEMTX compared with surgery alone in resected gastric cancer. A combined analysis of the EORTC GI Group and the ICCG

Articolo

Rapid intravenous premedication with dexamethasone prevents hypersensitivity reactions to paclitaxel.

Articolo

Relationship between 5-fluorouracil disposition, toxicity and dihydropyrimidine dehydrogenase activity in cancer patients.

Articolo

Renal safety of zoledronic acid in patients with bone metastases from breast cancer (BC) or other tumors treated with IV BisphosphonateS (BPS) for up to ten years

Abstract

Risk for second malignancies in non-Hodgkin's lymphoma survivors: a meta-analysis

Articolo

Safety and efficacy of T-DM1 in HER2 positive metastatic breast cancer patients: a real word experience.

Abstract

Safety and efficacy of odronextamab in patients with relapsed or refractory follicular lymphoma

Articolo

Sensitive detection of circulating breast cancer cells by reverse-transcriptase polymerase chain reaction of maspin gene

Articolo

The EUROCARE-3 database: Methodology of data collection, standardisation, quality control and statistical analysis

Articolo

The current and future role of the medical oncologist in the professional care for cancer patients: A position paper by the European Society for Medical Oncology (ESMO)

Articolo

The myocan phase II study of cyclophosphamide, oncovin, Myocet (TM) and prednisone plus rituximab (R-COMP) in elderly patients with diffuse large B-cell (DLBCL) non-Hodgkin lymphoma

Articolo

The oncogenic 30 and 69 bp deletion variants of the EBV LMP-1 gene are common in HIV-negative lymphoproliferations, both malignant and benign

Articolo

The paradox-breaking panRAF plus SRC family kinase inhibitor, CCT3833, is effective in mutant KRAS-driven cancers

Articolo

The prognostic role of post-induction FDG-PET in patients with follicular lymphoma: a subset analysis from the FOLL05 trial of the Fondazione Italiana Linfomi (FIL)

Articolo

The role of dose size in a chemotherapy regimen (ProMECE-CytaBOM) for the first-line treatment of large B-cell lymphomas: a randomized trial by the Gruppo Italiano Studio Linfomi (GISL)

Articolo

The sequential use of endocrine treatment for advanced breast cancer: where are we?

Articolo

The status of PD-L1 and tumor-infiltrating immune cells predict resistance and poor prognosis in BRAFi-treated melanoma patients harboring mutant BRAFV600

Articolo

The use of FDG-PET in the initial staging of 142 patients with follicular lymphoma: a retrospective study from the FOLL05 randomized trial of the Fondazione Italiana Linfomi

Articolo

Transferability to clinical practice of the results of controlled clinical trials: The case of antiemetic prophylactic treatment for cancer chemotherapy-induced nausea and vomiting

Articolo

Treatment of B cell grow grade non Hodgkin's lymphoma (NHL) with anti CD20 monoclonal antibody Rituximab. Cancer in the ederly.

Abstract

Treatment of metastatic renal cell carcinoma with constant-rate floxuridine infusion plus recombinant alpha 2b-interferon.

Articolo

Treatment of squamous cell carcinoma of the anal canal (SCCA): A new era?

Articolo

Trend of incidence, subsite distribution and staging of colorectal neoplasms in the 15-year experience of a specialised cancer registry.

Articolo

Tumor and normal interstitial fluid proteomic characterization in breast cancer patients receiving neoadjuvant chemotherapy

Articolo

Updating clinical recommendations for breast, colorectal and lung cancer treatments: an opportunity to improve methodology and clinical relevance

Articolo

Vinorelbine, gemcitabine, procarbazine and prednisone (ViGePP) regimen as salvage therapy in relapsed or refractory aggressive non-Hodgkin's lymphoma (NHL): Results of a phase II study conducted by the Gruppo Italiano per lo Studio dei Linfomi (gisl)

Articolo

No Results Found

«
‹

{pageNumber}

›
»

{startItem} - {endItem} di {itemsNumber}

Utilizzo dei cookie

Realizzato con VIVO | Designed by Cineca | 26.5.0.0